Loading clinical trials...
Loading clinical trials...
Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser for Verification of Predicted Refractive Outcome Using EpiMaster Software Considering Epithelial Remodelling
The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments.
The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments. The EpiMaster application software is not used in this clinical investigation, consequently, it is a merely observational investigation.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Pro Sight Eye Hospital
Chandigarh, Punjab Haryana, India
Uma Eye Clinic
Chennai, Tamil Nadu, India
Start Date
May 26, 2025
Primary Completion Date
November 1, 2026
Completion Date
June 1, 2027
Last Updated
January 9, 2026
150
ESTIMATED participants
PTK-PRK refractive treatment
PROCEDURE
Lead Sponsor
London Vision Clinic
Collaborators
NCT05458323
NCT04077086
NCT06565091
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions